• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性胆管炎继发于脂蛋白 X 的胃黄斑瘤。

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis.

机构信息

The University of Alabama at Birmingham, USA.

出版信息

J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221089488. doi: 10.1177/23247096221089488.

DOI:10.1177/23247096221089488
PMID:35403472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9006355/
Abstract

Primary biliary cholangitis (PBC) is a rare autoimmune disease characterized by intralobular bile duct destruction. Patients typically present with generalized symptoms including fatigue and pruritis, and less commonly, manifestations of lipid deposition including xanthomas and xanthelasmas. We report a case of a 31-year-old female with PBC-associated cirrhosis who had cutaneous xanthelasmas and diffuse gastric xanthomas secondary to hyperlipidemia and lipoprotein X that completely resolved following liver transplantation. While gastric xanthomas have been reported in patients with PBC previously, to our knowledge, this is the first case report of diffuse gastric xanthomas secondary to PBC reported to resolve following liver transplantation, suggesting that liver transplantation is curative for gastric xanthomatosis in patients with PBC-related cirrhosis.

摘要

原发性胆汁性胆管炎(PBC)是一种罕见的自身免疫性疾病,其特征为小叶间胆管破坏。患者通常表现为全身性症状,包括疲劳和瘙痒,以及较少见的脂质沉积表现,包括黄斑瘤和黄瘤。我们报告了一例 PBC 相关性肝硬化患者,其患有与高脂血症和脂蛋白 X 相关的皮肤黄斑瘤和弥漫性胃黄斑瘤,这些病变在肝移植后完全消退。虽然之前有报道称 PBC 患者存在胃黄斑瘤,但据我们所知,这是首例报告的 PBC 相关性肝硬化患者的弥漫性胃黄斑瘤在肝移植后消退的病例,表明肝移植对 PBC 相关肝硬化患者的胃黄色瘤病具有治愈作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/87fc0816d51c/10.1177_23247096221089488-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/b2bf6da7e06d/10.1177_23247096221089488-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/72c4e2f853f6/10.1177_23247096221089488-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/4239e8ed9916/10.1177_23247096221089488-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/87fc0816d51c/10.1177_23247096221089488-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/b2bf6da7e06d/10.1177_23247096221089488-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/72c4e2f853f6/10.1177_23247096221089488-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/4239e8ed9916/10.1177_23247096221089488-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20e/9006355/87fc0816d51c/10.1177_23247096221089488-fig4.jpg

相似文献

1
Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis.原发性胆汁性胆管炎继发于脂蛋白 X 的胃黄斑瘤。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221089488. doi: 10.1177/23247096221089488.
2
Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.非典型原发性胆汁性胆管炎导致伴有皮肤黄色瘤的胆管消失综合征:病例报告。
Diagn Pathol. 2022 Jul 4;17(1):57. doi: 10.1186/s13000-022-01228-1.
3
Early histopathologic changes in primary biliary cholangitis: does 'minimal change' primary biliary cholangitis exist? A pathologist's view.原发性胆汁性胆管炎的早期组织病理学改变:是否存在“微小变化”原发性胆汁性胆管炎?病理学家的观点。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):e7-e12. doi: 10.1097/MEG.0000000000001876.
4
Xanthomas and xanthelasmas in primary biliary cholangitis.原发性胆汁性胆管炎中的黄瘤和睑黄瘤
Med Clin (Barc). 2019 Jul 5;153(1):46. doi: 10.1016/j.medcli.2018.10.003. Epub 2018 Nov 20.
5
Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?抗线粒体抗体阴性的慢性非化脓性破坏性胆管炎。非典型原发性胆汁性肝硬化还是自身免疫性胆管炎?
J Clin Gastroenterol. 1996 Oct;23(3):191-8. doi: 10.1097/00004836-199610000-00007.
6
Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.原发性胆汁性肝硬化中抗线粒体抗体的血清学转阴:一例自身免疫性胆管炎病例
J Korean Med Sci. 1999 Feb;14(1):102-6. doi: 10.3346/jkms.1999.14.1.102.
7
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.抗线粒体抗体状态是否会影响原发性胆汁性肝硬化患者的治疗反应?熊去氧胆酸治疗及肝移植的结果。
Hepatology. 1997 Jul;26(1):22-6. doi: 10.1002/hep.510260103.
8
Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?抗线粒体抗体阴性原发性胆汁性胆管炎:真的是同一种疾病吗?
Clin Liver Dis. 2018 Aug;22(3):589-601. doi: 10.1016/j.cld.2018.03.009.
9
[How to understand the clinical significance of autoantibodies in primary biliary cholangitis].[如何理解原发性胆汁性胆管炎中自身抗体的临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):810-815. doi: 10.3760/cma.j.issn.1007-3418.2017.11.003.
10
Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?通过免疫印迹法检测自身免疫性胆管炎中抗-M2抗体的IgA、IgM和IgG亚类:自身免疫性胆管炎是原发性胆汁性肝硬化的早期阶段吗?
J Gastroenterol. 1999 Oct;34(5):607-12. doi: 10.1007/s005350050380.

本文引用的文献

1
Diffuse Gastric Xanthomatosis.弥漫性胃黄色瘤病
Clin Gastroenterol Hepatol. 2020 Oct;18(11):e132. doi: 10.1016/j.cgh.2019.07.064. Epub 2019 Aug 8.
2
Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.原发性胆汁性胆管炎:其病理特征与免疫病理机制
J Med Invest. 2017;64(1.2):7-13. doi: 10.2152/jmi.64.7.
3
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.奥贝胆酸治疗原发性胆汁性胆管炎的安慰剂对照临床试验。
N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840.
4
Lipid profiling of lipoprotein X: Implications for dyslipidemia in cholestasis.脂蛋白X的脂质分析:对胆汁淤积性血脂异常的意义。
Biochim Biophys Acta. 2016 Aug;1861(8 Pt A):681-7. doi: 10.1016/j.bbalip.2016.04.016. Epub 2016 Apr 22.
5
Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis.一名胆汁淤积患者中由脂蛋白X介导的严重高胆固醇血症。
Ann Hepatol. 2015 Nov-Dec;14(6):924-8. doi: 10.5604/16652681.1171785.
6
Primary biliary cirrhosis.原发性胆汁性肝硬化。
Lancet. 2015 Oct 17;386(10003):1565-75. doi: 10.1016/S0140-6736(15)00154-3. Epub 2015 Sep 11.
7
Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study.原发性胆汁性肝硬化患者发生心脑血管事件的风险:一项基于人群的队列研究。
Am J Gastroenterol. 2008 Nov;103(11):2784-8. doi: 10.1111/j.1572-0241.2008.02092.x. Epub 2008 Aug 27.
8
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review.原发性胆汁性肝硬化、高脂血症与动脉粥样硬化风险:一项系统评价
Atherosclerosis. 2007 Oct;194(2):293-9. doi: 10.1016/j.atherosclerosis.2006.11.036. Epub 2007 Jan 22.
9
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.高胆固醇血症与原发性胆汁性肝硬化的早期动脉粥样硬化病变无关。
Gut. 2006 Dec;55(12):1795-800. doi: 10.1136/gut.2005.079814. Epub 2006 Apr 21.
10
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation.脂蛋白-X通过防止低密度脂蛋白氧化来降低原发性胆汁性肝硬化中低密度脂蛋白的致动脉粥样硬化性。
J Lipid Res. 2004 Nov;45(11):2116-22. doi: 10.1194/jlr.M400229-JLR200. Epub 2004 Aug 16.